{"transactions":[{"id":945767,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:43:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":17796,"price":8.76,"value":155892.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $155,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":17796,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":17796},"source":{"system":"sec-edgar","filing":"0001561736-26-000002","document":"wk-form4_1767742986.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000156173626000002/wk-form4_1767742986.xml","form_type":"4"}},{"id":945766,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:43:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001561736-26-000002","document":"wk-form4_1767742986.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000156173626000002/wk-form4_1767742986.xml","form_type":"4"}},{"id":1309775,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T19:05:34.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":16991,"price":9.18,"value":155977.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuers Director Retainer Option Election Plan in lieu of retainer fees of $155,900"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":16991,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":16991},"source":{"system":"sec-edgar","filing":"0001599298-25-000023","document":"wk-form4_1736208323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929825000023/wk-form4_1736208323.xml","form_type":"4"}},{"id":1309774,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T19:05:34.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000023","document":"wk-form4_1736208323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929825000023/wk-form4_1736208323.xml","form_type":"4"}},{"id":1386511,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-10-15T17:08:13.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 11, 2024. The shares underlying the option shall vest in four equal annual installments, subject to the reporting person continuing to serve as a member of the Strategic Advisory Committee of the Board, with the first installment occurring on October 11, 2025."}],"balance_after":200000,"derivative":{"exercise_price":19.95,"expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001599298-24-000150","document":"wk-form4_1729026485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929824000150/wk-form4_1729026485.xml","form_type":"4"}},{"id":1687018,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:24:33.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":70492,"price":1.32,"value":93049.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $93,050."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":105492,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":70492},"source":{"system":"sec-edgar","filing":"0001599298-24-000012","document":"wk-form4_1704403461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929824000012/wk-form4_1704403461.xml","form_type":"4"}},{"id":1687017,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:24:33.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000012","document":"wk-form4_1704403461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929824000012/wk-form4_1704403461.xml","form_type":"4"}},{"id":2061760,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T16:12:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":44400,"price":1.67,"value":74148.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $74,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":79400,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":44400},"source":{"system":"sec-edgar","filing":"0001599298-23-000004","document":"wf-form4_167295314354996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929823000004/wf-form4_167295314354996.xml","form_type":"4"}},{"id":2061759,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T16:12:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-23-000004","document":"wf-form4_167295314354996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929823000004/wf-form4_167295314354996.xml","form_type":"4"}},{"id":2442838,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T16:01:45.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":58510,"price":1.13,"value":66116.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $66,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":83510,"derivative":{"exercise_price":2.82,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":58510},"source":{"system":"sec-edgar","filing":"0001599298-22-000005","document":"wf-form4_164141648612518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929822000005/wf-form4_164141648612518.xml","form_type":"4"}},{"id":2442837,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T16:01:45.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.82,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001599298-22-000005","document":"wf-form4_164141648612518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929822000005/wf-form4_164141648612518.xml","form_type":"4"}},{"id":2544172,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-12T08:40:30.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on October 7, 2021 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021."}],"balance_after":206250,"derivative":{"exercise_price":5.03,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000921895-21-002408","document":"form412566003_10112021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000092189521002408/form412566003_10112021.xml","form_type":"4"}},{"id":2544171,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-12T08:40:30.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 7, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on October 7, 2022."}],"balance_after":200000,"derivative":{"exercise_price":5.03,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000921895-21-002408","document":"form412566003_10112021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000092189521002408/form412566003_10112021.xml","form_type":"4"}},{"id":2700344,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T17:05:32.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":8026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":8026,"derivative":{"exercise_price":18.69,"exercise_date":"2021-09-05","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":8026},"source":{"system":"sec-edgar","filing":"0001209191-21-035006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919121035006/doc4.xml","form_type":"4"}},{"id":2700343,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T17:05:32.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":18.69,"exercise_date":"2021-06-20","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-035006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919121035006/doc4.xml","form_type":"4"}},{"id":3142129,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:21:49.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":14071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":14071,"derivative":{"exercise_price":10.66,"exercise_date":"2020-09-05","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":14071},"source":{"system":"sec-edgar","filing":"0001209191-20-030672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919120030672/doc4.xml","form_type":"4"}},{"id":3142128,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:21:49.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":10.66,"exercise_date":"2020-06-18","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-030672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919120030672/doc4.xml","form_type":"4"}},{"id":3520152,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T16:14:15.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":9900,"derivative":{"exercise_price":13.03,"exercise_date":"2019-09-05","expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0001209191-19-030882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919119030882/doc4.xml","form_type":"4"}},{"id":3520151,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T16:14:15.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":13.03,"exercise_date":"2019-06-16","expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-030882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919119030882/doc4.xml","form_type":"4"}},{"id":3698797,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-09T16:12:52.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":2931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the date of the Issuer's Annual Meeting to be held in 2019, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":2931,"derivative":{"exercise_price":13.22,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":2931},"source":{"system":"sec-edgar","filing":"0001209191-19-003029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919119003029/doc4.xml","form_type":"4"}},{"id":3918225,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-24T18:35:17.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":15.27,"exercise_date":"2018-06-23","expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-033146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919118033146/doc4.xml","form_type":"4"}},{"id":4171090,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-06T16:42:54.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares subject to the option will vest on November 2, 2018, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":65000,"derivative":{"exercise_price":23.08,"exercise_date":"2018-11-02","expiration_date":"2027-11-02","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-17-059424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000120919117059424/doc4.xml","form_type":"4"}}]}